Misuse of Drugs Act 1971

Last updated

Misuse of Drugs Act 1971 [1]
Act of Parliament
Royal Coat of Arms of the United Kingdom (Variant 1, 2022).svg
Parliament of the United Kingdom
Long title An Act to make new provision with respect to dangerous or otherwise harmful drugs and related matters, and for purposes connected therewith.
Citation 1971 c. 38
Introduced by Reginald Maudling
Territorial extent England and Wales; Scotland; Northern Ireland
Dates
Royal assent 27 May 1971
Status: Amended
Text of statute as originally enacted
Revised text of statute as amended

The Misuse of Drugs Act 1971 [1] (c. 38) is an act of the Parliament of the United Kingdom. It represents action in line with treaty commitments under the Single Convention on Narcotic Drugs, [2] the Convention on Psychotropic Substances, [3] and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. [4]

Contents

Offences under the act include: [5]

It is often presented[ by whom? ] as little more than a list of prohibited drugs and of penalties linked to their possession and supply. In practice, however, the act establishes the Home Secretary as a key player in a drug licensing system. Therefore, for example, various opiates are available legally as prescription-only medicines, and cannabis (hemp) [6] may be grown under licence for 'industrial purposes'. The Misuse of Drugs Regulations 2001, [7] created under the 1971 Act, are about licensing of production, possession and supply of substances classified under the act.

The act creates three classes of controlled substances, A, B, and C, and ranges of penalties for illegal or unlicensed possession and possession with intent to supply are graded differently within each class. The lists of substances within each class can be amended by Order in Council, so the Home Secretary can list new drugs and upgrade, downgrade or delist previously controlled drugs with less of the bureaucracy and delay associated with passing an act through both Houses of Parliament.

Critics of the Act such as David Nutt say that its classification is not based on how harmful or addictive the substances are, and that it is unscientific to omit substances like tobacco and alcohol.

Provisions

Section 37 – Interpretation

Section 37(5) became spent on the repeal of sections 8 to 10 of the Pharmacy and Poisons Act 1933. [8] It was repealed by Group 7 of Part 17 of Schedule 1 to the Statute Law (Repeals) Act 2004.

List of controlled drugs

The Act sets out four separate categories: Class A, Class B, Class C and temporary class drugs. Substances may be removed and added to different parts of the schedule by statutory instrument, provided a report of the Advisory Council on the Misuse of Drugs has been commissioned and has reached a conclusion, although the Secretary of State is not bound by the council's findings.

Penalties

The penalties for drug offences depend on the class of drug involved. These penalties are enforced against those who do not have a valid prescription or licence to possess the drug in question. Thus, it is not illegal for someone to possess heroin, a Class A drug, so long as it was administered to them legally (by prescription).

Class A drugs attract the highest penalty, and imprisonment is both "proper and expedient". [9] The maximum penalties possible are as follows: [10]

OffenceCourtClass AClass B/Temporary classClass C
Possession Magistrates 6 months / £5000 fine3 months / £2500 fine3 months / £500 fine
Crown 7 years / unlimited fine5 years / unlimited fine2 years / unlimited fine
Supply and possession
with intent to supply		 Magistrates 6 months / £5000 fine6 months / £5000 fine3 months / £2000 fine
Crown Life [11] / unlimited fine14 years / unlimited fine14 years / unlimited fine

International cooperation

The act makes it a crime to assist in, incite, or induce, the commission of an offence, outside the UK, against another nation's corresponding law on drugs. A corresponding law is defined as another country's law "providing for the control and regulation in that country of the production, supply, use, export and import of drugs and other substances in accordance with the provisions of the Single Convention on Narcotic Drugs" or another drug control treaty to which the UK and the other country are parties. An example might be lending money to a United States drug dealer for the purpose of violating that country's Controlled Substances Act.

History

The Drugs (Prevention of Misuse) Act 1964 controlled amphetamines in the United Kingdom in advance of international agreements and was later used to control LSD.

Before 1971, the UK had a relatively liberal drugs policy and it was not until United Nations influence had been brought to bear that controlling incidental drug activities was employed to effectively criminalise drugs use. It is noted that bar the smoking of opium and cannabis; Section 8, part d, under the 1971 Act was not an offence (relating to the prosecution of the owner of a premises/building inside of which controlled drugs were being used). Section 8 of the Misuse of Drugs Act 1971 [12] was amended by Regulation 13 of Misuse of Drugs Regulations 1985 [13] and Section 38 of the Criminal Justice and Police Act 2001. [14] These amendments were however repealed in 2005 by Schedule 1 (part 6) of the Drugs Act 2005,. [15] [16]

The Current Section 8 covers: people knowingly allowing premises they own, manage, or have responsibility for, to be used by any other person for:

Criticism and controversy

Notable criticism of the act includes:

The Transform Drug Policy Foundation offers rational criticism of the harms caused by the Government's current prohibitionist drug policy. [21] The Drug Equality Alliance (DEA) has launched legal actions against the UK Government's partial and unequal administration of the Act's discretionary powers, making particular reference to the arbitrary exclusion of alcohol and tobacco on the subjective grounds of historical and cultural precedents contrary to the Act's policy and objects. [22]

Classification of cannabis has become especially controversial. In 2004, cannabis [6] was reclassified from class B to class C, [23] in accordance with advice from the Advisory Council on the Misuse of Drugs (ACMD). In 2009, it was returned to class B, [24] against ACMD advice.

In February 2009 the UK government was accused by its most senior expert drugs adviser Professor David Nutt of making a political decisions with regard to drug classification in rejecting the scientific advice to downgrade ecstasy from a class A drug. The Advisory Council on the Misuse of Drugs (ACMD) report on ecstasy, based on a 12-month study of 4,000 academic papers, concluded that it is nowhere near as dangerous as other class A drugs such as heroin and crack cocaine, and should be downgraded to class B. The advice was not followed. [25] Jacqui Smith, then Home Secretary, was also widely criticised by the scientific community for bullying Professor David Nutt into apologising for his comments that, in the course of a normal year, more people died from falling off horses than died from taking ecstasy. [26] Professor Nutt was later sacked by Alan Johnson (Jacqui Smith's successor as Home Secretary); Johnson saying "It is important that the government's messages on drugs are clear and as an advisor you do nothing to undermine public understanding of them. I cannot have public confusion between scientific advice and policy and have therefore lost confidence in your ability to advise me as Chair of the ACMD." [27] [28]

In May 2011, a report named Taking Drugs Seriously was released by Demos. It discusses several issues with the current system, since its enactment in 1971. It states that the constant presence of new drugs will make it difficult for the government to keep up with the latest situation - over 600 drugs are now classified under the act. Comparison levels of harm previously demonstrated by David Nutt show that alcohol and tobacco were among the most lethal, while some class A drugs, such as MDMA, LSD, and magic mushrooms, were among the least harmful. [29]

Use of controlled substances for research

A common misunderstanding amongst researchers is that most national laws (including the Misuse for Drugs Act) allows the use of small amounts of a controlled substance for non-clinical / non-in vivo research without licences. A typical use case might be having a few milligrams or microlitres of a controlled substance within larger chemical collections (often tens of thousands of chemicals) for in vitro screening. Researchers often believe that there is some form of "research exemption" for such small amounts. This incorrect view may be further re-enforced by R&D chemical suppliers often stating and asking scientists to confirm that anything bought is for research use only.

A further misconception is that the Misuse of Drugs Act simply lists a few hundred substances (e.g. MDMA, Fentanyl, Amphetamine, etc.) and compliance can be achieved via checking a CAS number, chemical name or similar identifier. However, the reality is that in most cases all ethers, esters, salts and stereo isomers are also controlled and it is impossible to simply list all of these. The act contains several "generic statements" or "chemical space" laws, which aim to control all chemicals similar to the "named" substance, these provide detailed descriptions similar to Markushes, a good example of a few of these are found in the Misuse of Drugs Act 1971 (amendment) order 2013. [30]

Due to this complexity in legislation the identification of controlled chemicals in research is often carried out computationally, either by in house systems maintained a company's sample logistics department or by the use commercial software solutions. [31] Automated systems are often required as many research operations can often have chemical collections running into 10Ks of molecules at the 1–5 mg scale, which are likely to include controlled substances, especially within medicinal chemistry research, even if the core research of the company is not narcotic or psychotropic drugs. [32] These may not have been controlled when created, but they have subsequently been declared controlled, or fall within chemical space close to known controlled substances.

There are no specific research exemptions in the Misuse of Drugs Act. However, the associated Misuse of Drug Regulations 2001 [33] does exempt products containing less than 1 mg of a controlled substance (1 μg for lysergide and derivatives) so long as a number of requirements are met, including that it cannot be recovered by readily applicable means, does not pose a risk to human health and is not meant for administration to a human or animal.

Although this does at first seem to allow research use, in most circumstances the sample, by definition, is "recoverable" - in order to prepare it for use the sample is "recovered" into an assay buffer or solvent such as DMSO or water. In 2017 the Home Office also confirmed that the 1 mg limit applies to the total of all preparations across the entire container in the case of sample microtitre plates. [34] Given this, most companies and researchers choose not to rely on this exemption.

However according to Home Office licensing, "University research departments generally do not require licences to possess and supply drugs in schedules 2, 3, 4 part I, 4 part II and schedule 5, but they do require licences to produce any of those drugs and to produce, possess and/or supply drugs in schedule 1". [35]

See also

Notes

  1. ↑ Plants containing mescaline not illegal, only an extract of the substance.

Related Research Articles

<span class="mw-page-title-main">Controlled Substances Act</span> United States drug-regulating law

The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated. It was passed by the 91st United States Congress as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and signed into law by President Richard Nixon. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs.

<span class="mw-page-title-main">Drug prohibition</span> History, effects and enforcement of the prohibition of drugs

The prohibition of drugs through sumptuary legislation or religious law is a common means of attempting to prevent the recreational use of certain intoxicating substances.

<span class="mw-page-title-main">Single Convention on Narcotic Drugs</span> 1961 international treaty regulating narcotic drugs

The Single Convention on Narcotic Drugs, 1961 is an international treaty that controls activities of specific narcotic drugs and lays down a system of regulations for their medical and scientific uses; it also establishes the International Narcotics Control Board.

Cannabis classification in the United Kingdom refers to the class of drugs, as determined by the Misuse of Drugs Act 1971, that cannabis is placed in. Between 1928 and 2004 and since 2009, it has been classified as a class B drug. From 2004 to 2009, it was a class C drug. At present, it is a class B, with very limited exceptions.

<span class="mw-page-title-main">Misuse of Drugs Act 1975</span> Act of Parliament in New Zealand

The Misuse of Drugs Act 1975 is a New Zealand drug control law that classifies drugs into three classes, or schedules, purportedly based on their projected risk of serious harm. However, in reality, classification of drugs outside of passing laws, where the restriction has no legal power, is performed by the governor-general in conjunction with the Minister of Health, neither of whom is actually bound by law to obey this restriction.

A controlled substance is generally a drug or chemical whose manufacture, possession and use is regulated by a government, such as illicitly used drugs or prescription medications that are designated by law. Some treaties, notably the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, provide internationally agreed-upon "schedules" of controlled substances, which have been incorporated into national laws; however, national laws usually significantly expand on these international conventions.

The Advisory Council on the Misuse of Drugs (ACMD) is a British statutory advisory non-departmental public body, which was established under the Misuse of Drugs Act 1971.

<span class="mw-page-title-main">AL-LAD</span> Chemical compound (psychedelic drug)

AL-LAD, also known as 6-allyl-6-nor-LSD, is a psychedelic drug and an analog of lysergic acid diethylamide (LSD). It is described by Alexander Shulgin in the book TiHKAL. It is synthesized starting from nor-LSD as a precursor, using allyl bromide as a reactant.

<span class="mw-page-title-main">PRO-LAD</span> Chemical compound

PRO-LAD is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PRO-LAD is a psychedelic drug similar to LSD, and is around as potent as LSD itself with an active dose reported at between 100 and 200 micrograms.

<span class="mw-page-title-main">Phenazepam</span> Benzodiazepine drug

Phenazepam is a benzodiazepine drug, first developed in the Soviet Union in 1975, and now produced in Russia and several other countries.

Drug classification: making a hash of it? is a 2006 report written by the UK Science and Technology Select Committee and submitted to the British House of Commons. The report suggested that the current system of recreational drug classification in the UK was arbitrary and unscientific, suggesting a more scientific measure of harm be used for classifying drugs. The report also strongly criticised the decision to place fresh psychedelic mushrooms in Class A, the same category as cocaine and heroin.

A drug policy is the policy regarding the control and regulation of psychoactive substances, particularly those that are addictive or cause physical and mental dependence. While drug policies are generally implemented by governments, entities at all levels may have specific policies related to drugs.

<span class="mw-page-title-main">Mephedrone</span> Synthetic stimulant drug

Mephedrone, also known as 4-methylmethcathinone, 4-MMC, and 4-methylephedrone, is a synthetic stimulant drug of the amphetamine and cathinone classes. Slang names include drone, M-CAT, White Magic, meow meow and bubble. It is chemically similar to the cathinone compounds found in the Khat plant of eastern Africa. It comes in the form of tablets or crystals, which users can swallow, snort or inject, producing effects similar to those of MDMA, amphetamines and cocaine.

<span class="mw-page-title-main">Convention on Psychotropic Substances</span> 1971 UN treaty to regulate recreational drugs

The Convention on Psychotropic Substances of 1971 is a United Nations treaty designed to control psychoactive drugs such as amphetamine-type stimulants, barbiturates, benzodiazepines, and psychedelics signed in Vienna, Austria on 21 February 1971. The Single Convention on Narcotic Drugs of 1961 did not ban the many newly discovered psychotropics, since its scope was limited to drugs with cannabis, coca and opium-like effects.

<span class="mw-page-title-main">Synthetic cannabinoids</span> Designer drugs

Synthetic cannabinoids are a class of designer drug molecules that bind to the same receptors to which cannabinoids in cannabis plants attach. These novel psychoactive substances should not be confused with synthetic phytocannabinoids or synthetic endocannabinoids from which they are in many aspects distinct.

<span class="mw-page-title-main">Drug policy of Canada</span> Overview of the drug policy of Canada

Canada's drug regulations are measures of the Food and Drug Act and the Controlled Drugs and Substances Act. In relation to controlled and restricted drug products, the Controlled Drugs and Substances Act establishes eight schedules of drugs and new penalties for the possession, trafficking, exportation and production of controlled substances as defined by the Governor-in-Council. Drug policy of Canada has traditionally favoured punishment for the smallest of offences, but this convention was partially broken in 1996 with the passing of the Controlled Drugs and Substances Act.

<span class="mw-page-title-main">2-Diphenylmethylpyrrolidine</span> Stimulant designer drug

2-Diphenylmethylpyrrolidine (Desoxy-D2PM), also known as 2-benzhydrylpyrrolidine, is a stimulant psychoactive drug. It is the 4-dehydroxylated structural analog of diphenylprolinol (D2PM), and is also similar in structure to desoxypipradrol (2-DPMP), both of which act as norepinephrine-dopamine reuptake inhibitors (NDRIs). Like D2PM and 2-DPMP, Desoxy-D2PM is sold as a designer drug and has been used in the manufacture of legal highs. It has been marketed under the names A3A New Generation, A3A Methano, and Green Powder, and has been reported to cause hallucinations, violent behavior, dilated pupils, tachycardia, and high blood pressure. Literature data suggest that it can produce the same psychotropic effects as other stimulants, but with a longer duration of action.

<span class="mw-page-title-main">Methoxetamine</span> Dissociative drug

Methoxetamine, abbreviated as MXE, is a dissociative hallucinogen that has been sold as a designer drug. It differs from many dissociatives such as ketamine and phencyclidine (PCP) that were developed as pharmaceutical drugs for use as general anesthetics in that it was designed specifically to increase the antidepressant effects of ketamine.

Drugs considered addictive or dangerous in the United Kingdom are called "controlled substances" and regulated by law. Until 1964 the medical treatment of dependent drug users was separated from the punishment of unregulated use and supply. Under this policy drug use remained low; there was relatively little recreational use and few dependent users, who were prescribed drugs by their doctors as part of their treatment. From 1964 drug use was decreasingly criminalised, with the framework still in place as of 2014 largely determined by the Misuse of Drugs Act.

<span class="mw-page-title-main">25C-NBF</span> Chemical compound

25C-NBF is a derivative of the phenethylamine hallucinogen 2C-C, which acts as a highly potent partial agonist for the human 5-HT2A receptor.

References

  1. 1 2 The citation of this act by this short title is authorised by section 40(1) of this act.
  2. ↑ "Single Convention on Narcotic Drugs, 1961, United Nations Office on Drugs and Crime website, accessed 6 February 2009". Unodc.org. 24 October 2007. Retrieved 23 January 2011.
  3. ↑ "Convention on Psychotropic Substances, 1971, United Nations Office on Drugs and Crime website, accessed 6 February 2009". Unodc.org. 24 October 2007. Retrieved 23 January 2011.
  4. ↑ "Convention against the Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988, United Nations Office on Drugs and Crime website, accessed 6 February 2009". Unodc.org. 24 October 2007. Retrieved 23 January 2011.
  5. ↑ "Misuse of Drugs Act, Home Office representation of the act, Home Office website, accessed 27 January 2009". Drugs.homeoffice.gov.uk. Archived from the original on 4 May 2010. Retrieved 23 January 2011.
  6. 1 2 All varieties of cannabis, including those grown as hemp, are controlled under the act, not just drug varieties.
  7. ↑ Statutory Instrument 2001 No. 3998 The Misuse of Drugs Regulations 2001
  8. ↑ Archbold Criminal Pleading, Evidence and Practice. 1999. Paragraph 26-128 at page 2209.
  9. ↑ R v Aramah (1982) 4 Cr App R (S) 407, per Lord Lane CJ
  10. ↑ Class A, B and C drugs, Home Office website, accessed 27 January 2009 Archived 4 August 2007 at the Wayback Machine
  11. ↑ Increased from 14 years to life in 1985: Controlled Drugs (Penalties) Act 1985.
  12. ↑ "Misuse of Drugs Act 1971". Opsi.gov.uk. Retrieved 23 January 2011.
  13. ↑ http://www.drugshelp.info/downloads/modr1985.pdf The Misuse of Drugs Regulations 1985
  14. ↑ "The Misuse of Drugs Regulations 2001". Opsi.gov.uk. 16 July 2010. Retrieved 23 January 2011.
  15. ↑ "Drugs Act 2005". Opsi.gov.uk. 16 July 2010. Retrieved 23 January 2011.
  16. ↑ "Tables of legislative effects - Statute Law Database". Statutelaw.gov.uk. Retrieved 23 January 2011.
  17. ↑ DrugScope. "RESOURCES | What are the UK drug laws?". DrugScope. Archived from the original on 27 September 2011. Retrieved 23 January 2011.
  18. ↑ "Microsoft Word - HC1031.doc" (PDF). Retrieved 23 January 2011.
  19. ↑ Nutt, D.; King, L. A.; Saulsbury, W.; Blakemore, C. (2007). "Development of a rational scale to assess the harm of drugs of potential misuse". The Lancet. 369 (9566): 1047–1053. doi:10.1016/S0140-6736(07)60464-4. PMID   17382831. S2CID   5903121.
  20. ↑ "Scientists want new drug rankings, BBC News website, 23 March 2007, accessed 27 January 2009". BBC News. 23 March 2007. Retrieved 23 January 2011.
  21. ↑ "Transform Drug Policy Foundation website, accessed 30 January 2009". Tdpf.org.uk. Retrieved 23 January 2011.
  22. ↑ "Drug Equality Alliance - Mission". Drug Equality Alliance. Retrieved 28 August 2009.
  23. ↑ "The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003 (No. 3201), OPSI website, accessed 27 January 2009". Statutelaw.gov.uk. 29 January 2004. Retrieved 23 January 2011.
  24. ↑ "The Misuse of Drugs Act 1971 (Amendment) Order 2008 (No. 3130), OPSI website, accessed 27 January 2009". Statutelaw.gov.uk. 10 December 2008. Retrieved 23 January 2011.
  25. ↑ Travis, Alan (February 2009). "Government criticised over refusal to downgrade ecstasy". The Guardian.
  26. ↑ Kmietowicz Z (2009). "Home secretary accused of bullying drugs adviser over comments about ecstasy". BMJ. 338: b612. doi:10.1136/bmj.b612. PMID   19218327. S2CID   28874033.
  27. ↑ Mark Easton (30 October 2009). "Nutt gets the sack". BBC News. Retrieved 18 December 2011.
  28. ↑ Mark Tran (30 October 2009). "Government drug adviser David Nutt sacked". The Guardian. Retrieved 18 December 2011.
  29. ↑ Jonathan Birdwell; Jake Chapman; Nicola Singleton (5 March 2011). taking drugs seriously: A Demos and UK Drug Policy Commission report on legal highs (PDF). Demos. ISBN   978-1-906693-68-8 . Retrieved 18 December 2012.
  30. ↑ "The Misuse of Drugs Act 1971 (Amendment) Order 2013". www.legislation.gov.uk. Retrieved 22 January 2019.
  31. ↑ "Scitegrity | Controlled Substances Squared". www.scitegrity.com. Retrieved 22 January 2019.
  32. ↑ "Controlled Substances found in research and chemical suppliers collections". www.scitegrity.com.
  33. ↑ "The Misuse of Drugs Regulations 2001". www.legislation.gov.uk. Retrieved 22 January 2019.
  34. ↑ "Research Exemptions | Controlled Substances | In Vitro". blog.scitegrity.com. Retrieved 5 January 2023.
  35. ↑ "Controlled drugs: licences, fees and returns". GOV.UK. Retrieved 27 February 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.